You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 23, 2024

~ Buy the OXLUMO (lumasiran sodium) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR OXLUMO

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for OXLUMO

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT04152200 ↗	A Study to Evaluate Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1	Active, not recruiting	Alnylam Pharmaceuticals	Phase 3	2020-01-21	The purpose of this study is to evaluate the efficacy, safety, pharmacokinetics (PK), and pharmacodynamics (PD) of lumasiran in patients with Advanced Primary Hyperoxaluria Type 1 (PH1).
NCT05161936 ↗	A Study to Evaluate Lumasiran in Adults With Recurrent Calcium Oxalate Kidney Stone Disease and Elevated Urinary Oxalate Levels	Not yet recruiting	Alnylam Pharmaceuticals	Phase 2	2021-12-01	The primary purpose of this study is to evaluate the effect of lumasiran on the percent change in urinary oxalate excretion in patients with recurrent calcium oxalate kidney stone disease.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for OXLUMO

Condition Name

Chart
Table

Condition Name for OXLUMO
Intervention	Trials
Recurrent Calcium Oxalate Kidney Stone Disease	1
Elevated Urinary Oxalate Levels	1
Primary Hyperoxaluria	1
Primary Hyperoxaluria Type 1	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for OXLUMO
Intervention	Trials
Nephrolithiasis	1
Kidney Calculi	1
Calculi	1
Hyperoxaluria, Primary	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for OXLUMO

Trials by Country

Map
Table

Trials by Country for OXLUMO
Location	Trials
United States	3
Belgium	1
Italy	1
Netherlands	1
United Kingdom	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for OXLUMO
Location	Trials
Texas	1
New York	1
Minnesota	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for OXLUMO

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for OXLUMO
Clinical Trial Phase	Trials
Phase 3	1
Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for OXLUMO
Clinical Trial Phase	Trials
Active, not recruiting	1
Not yet recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for OXLUMO

Sponsor Name

Chart
Table

Sponsor Name for OXLUMO
Sponsor	Trials
Alnylam Pharmaceuticals	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for OXLUMO
Sponsor	Trials
Industry	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.